The Epidemic of Low Testosterone

Hypogonadism is a term referring to underactivity of the sexual organs or gonads, sometimes called the male menopause.  Hypogonadic men produce smaller than normal amounts of testosterone in their testicles resulting in deficient blood levels of the hormone.

Testosterone is an anabolic steroid. Testosterone creates and maintains the virile functioning of the male sexual organs and all other organs: potency in the gonads, strength in the muscles, energy in the mind and vitality of all the cells and tissues where testosterone plays a role.

By late teens, testosterone levels reach their lifetime high level typically 800 to 1200 ng/dl before declining throughout the remainder of adulthood. After age 30, testosterone levels may decline about 1 percent per year.

Here is a rough gauge of men’s testosterone levels by age:

age testosterone levels (ng/dl)
20 1000
30 900
40 800
50 700
60 500
70 400
80 300
90 200

It is not uncommon to observe low testosterone levels in men, young or old. Study shows that the average testosterone level of a man has decreased by about 1% per year since the 1980s and this is not just affecting middle-aged men. Men in 20s, 30s are being diagnosed with levels of testosterone that would normally be seen in an 80-year-old man. Testosterone levels in men have been declining rapidly worldwide and I encounter this phenomenon in my practice manifested in various symptoms and signs: mental health problem or fatigue and energy problem, male fertility or sexual health problem. Even recurrent pregnancy losses experienced by females can be attributed to low testosterone problems.


In adult males, approximately 90 to 95 per cent of testosterone is produced in specialized cells in the testicles called Leydig cells. Primary hypogonadism denotes testicular Leydig cells have lost the capacity to secrete the hormone at youthful levels. This can be seen in chronic disease states, such as rheumatoid arthritis, renal failure, cirrhosis of the liver, chronic obstructive pulmonary disease, hemochromatosis, AIDs, cancer, by the use of chemotherapy drugs or immune-suppressants.


In this case, gonadotrophins LH and FSH in the brain become raised to a high level, indicating an ongoing effort by the pituitary and the hypothalamus to stimulate testicular activity. High gonadotrophins combined with low testosterone is normally an indicator of classic testicular failure with low testosterone production.


Secondary hypogonadism denotes that the Leydig cell capacity may be unimpaired, but the control glands in the brain are not asking them to use that capacity. The pituitary ought to be dispatching hormonal messengers but if levels of FSH and LH remain low, this would suggest that the problem lies with the central control centre in the pituitary and hypothalamus in the brain not sending requests for more testosterone.

In middle-aged men, it seems secondary hypogonadism is the more common cause of testosterone deficiency. Simply replacing testosterone has no effect or can continue downregulation of testosterone and sperm production.

It is therefore not surprising that only about 5 per cent of impotent men find treatment with testosterone supplementation to be effective and papers concluding that hormonal imbalance is not the major reason for male decline are misleading and inaccurate.

Secondary hypogonadism can be caused by suppressed pituitary or hypothalamic function or brain disorders such as tumours, infarction, trauma, vascular defects, hyperprolactinemia, isolated deficiency of luteinizing hormone or follicle-stimulating hormone, nutritional deficiency or starvation, alcoholism, massive obesity, glucocorticoid drugs, Kallman’s syndrome, radiation, etc.


Besides these straightforward testosterone deficiencies in primary and secondary hypogonadism, there is much-nuanced testosterone deficiency which is far more common and clinically relevant. I discuss this issue in a separate article.


Dr Ryu’s articles :

How man is oestrogenised

What is Testosterone Resistance?

Problem with Testosterone replacement therapy

He has zero sperm!

Restoring male fertility

Belly Fat, the enemy of manhood

A man’s sperm count is a marker of his general health

Problem with Testosterone replacement therapy

Taking Viagra for Erectile Dysfunction?

Common painkillers don’t only kill pain

Insulin Resistance: The critical piece of the puzzle

Early-onset Balding, the first sign of Insulin Resistance

Agnes Ryu

Agnes Ryu

Dr. Ryu is a clinician and biochemist specializing in integrative medicine. Her clinical interests include fertility, hormones, metabolism, healthy ageing, menopause, and natural breast cancer care. As an integrative practitioner, Dr. Ryu aims to uncover the root causes of health issues and strives to empower patients with the knowledge and tools to take charge of their own health.

Shopping cart0
There are no products in the cart!